UPDATED Sep 24, 2025
Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$741.85 | -2.4% | -19.8% | US$670.6b | US$884.31 | PE48.3x | E21.3% | 0.8% | ||
JNJ | US$176.69 | -0.3% | 10.0% | US$425.3b | US$179.64 | PE18.8x | E2.1% | 2.9% | ||
ABBV | US$219.99 | -0.4% | 15.0% | US$393.3b | US$227.22 | PE104.4x | E27.2% | 3.0% | ||
MRK | US$79.67 | -1.8% | -30.6% | US$199.7b | US$101.60 | PE12.1x | E8.5% | 4.1% | ||
TMO | US$468.00 | -1.0% | -22.0% | US$177.4b | US$546.76 | PE26.8x | E9.5% | 0.4% | ||
AMGN | US$279.22 | 1.6% | -10.8% | US$154.4b | US$311.46 | PE22.7x | E9.5% | 3.4% | ||
GILD | US$113.67 | 1.3% | 38.3% | US$141.9b | US$125.19 | PE22.3x | E12.8% | 2.8% | ||
PFE | US$24.09 | 0.2% | -16.7% | US$137.2b | US$28.90 | PE12.8x | E-1.1% | 7.1% | ||
DHR | US$185.91 | -3.6% | -30.6% | US$135.8b | US$243.43 | PE39x | E16.4% | 0.7% | ||
VRTX | US$376.62 | -2.7% | -18.4% | US$97.4b | US$479.64 | PE26.5x | E13.4% | n/a | ||
BMY | US$44.16 | -4.3% | -11.6% | US$91.4b | US$53.00 | PE17.8x | E6.2% | 5.6% | ||
ZTS | US$141.67 | -3.6% | -26.0% | US$63.2b | US$190.09 | PE24x | E7.2% | 1.4% | ||
ALNY | US$458.37 | 1.5% | 68.1% | US$59.6b | US$447.15 | PS24.4x | E54.1% | n/a | ||
REGN | US$576.98 | -1.5% | -44.0% | US$58.9b | US$722.20 | PE13.4x | E8.5% | 0.6% | ||
ONC | US$329.84 | -0.7% | 59.6% | US$36.2b | US$370.45 | PS8x | E48.6% | n/a | ||
A | US$124.38 | -1.8% | -10.8% | US$35.7b | US$138.97 | PE28.9x | E10.8% | 0.8% | ||
IQV | US$181.24 | -2.9% | -21.8% | US$31.7b | US$216.42 | PE24.9x | E13.1% | 0% | ||
INSM | US$141.00 | -2.6% | 93.9% | US$30.7b | US$159.13 | PS74.9x | E64.7% | n/a | ||
MTD | US$1,242.28 | -2.5% | -12.5% | US$25.9b | US$1,306.36 | PE30.8x | E7.6% | n/a | ||
BNTX | US$99.75 | 1.6% | -13.9% | US$23.6b | US$136.98 | PS7.1x | E19.1% | n/a | ||
NTRA | US$163.91 | -8.9% | 32.3% | US$22.5b | US$197.33 | PS11.5x | E67.6% | n/a | ||
TEVA | US$19.27 | 4.8% | 10.4% | US$22.3b | US$23.89 | PS1.3x | E31.1% | 0% | ||
RPRX | US$35.77 | 0.4% | 29.4% | US$21.1b | US$45.00 | PE15.1x | E4.4% | 2.5% | ||
BIIB | US$137.67 | -5.0% | -27.2% | US$20.4b | US$170.03 | PE13.2x | E7.2% | n/a |